Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Medically reviewed by Min Clinic Staff | Updated: January 2026
Dosing and uses of Translarna (ataluren)
Duchenne Muscular Dystrophy
Pending FDA approvaL
Aniridia (Orphan)
Orphan designation for treatment of aniridia
Sponsor
- PTC Therapeutics, Inc; 100 Corporate Court; South Plainfield, New Jersey 07080
Pharmacology of Translarna (ataluren)
Mechanism of action
Possibly causes ribosomes to be less sensitive to premature stop codons (ie, ‘read-through’) if mRNA contains a mutation causing premature stop codons or nonsense codons
